The mechanisms of ultra-low dose opioid agonist-antagonist

被引：4
|
作者：
Wong, Chih-Shung [1 ]
机构：
[1] Cathay Gen Hosp, Dept Anesthesiol, Taipei, Taiwan
来源：
JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION | 2011年 / 110卷 / 10期
关键词：
MORPHINE;
D O I：
10.1016/j.jfma.2011.08.013
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：666 / 666
页数：1
相关论文
共 50 条
  • [31] Chronic very low dose naltrexone administration attenuates opioid withdrawal expression
    Mannelli, P
    Gottheil, E
    Peoples, JF
    Oropeza, VC
    Van Bockstaele, EJ
    BIOLOGICAL PSYCHIATRY, 2004, 56 (04) : 261 - 268
  • [32] Treatment With the Delta Opioid Agonist UFP-512 Alleviates Chronic Inflammatory and Neuropathic Pain: Mechanisms Implicated
    Polo, Sara
    Felipe Diaz, Andres
    Gallardou, Nuria
    Leanez, Sergi
    Balboni, Gianfranco
    Pol, Olga
    FRONTIERS IN PHARMACOLOGY, 2019, 10
  • [33] Nalbuphine, a kappa opioid receptor agonist and mu opioid receptor antagonist attenuates pruritus, decreases IL-31, and increases IL-10 in mice with contact dermatitis
    Inan, Saadet
    Huerta, Alvaro T.
    Jensen, Liselotte E.
    Dun, Nae J.
    Cowan, Alan
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2019, 864
  • [34] Effects of ultra-low doses of nicotine on the expression of morphine-induced conditioned place preference in mice
    Shams, Jamal
    Sahraei, Hedayat
    Gholami, Azam
    Haeri-Rohani, Ali
    Alaf-Javadi, Mahrooz
    Sepehri, Houri
    Salimi, Seyed H.
    Ghoshooni, Hassan
    BEHAVIOURAL PHARMACOLOGY, 2006, 17 (07): : 629 - 635
  • [35] LPK-26, a novel κ-opioid receptor agonist with potent antinociceptive effects and low dependence potential
    Tao, Yi-Min
    Li, Qing-Lin
    Zhang, Cong-Fen
    Xu, Xue-Jun
    Chen, Jie
    Ju, Ya-Wen
    Chi, Zhi-Qiang
    Long, Ya-Qiu
    Liu, Jing-Gen
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2008, 584 (2-3) : 306 - 311
  • [36] Antinociceptive tolerance to the mu-opioid agonist DAMGO is dose-dependently reduced by MK-801 in rats
    Mao, JR
    Price, DD
    Lu, J
    Mayer, DJ
    NEUROSCIENCE LETTERS, 1998, 250 (03) : 193 - 196
  • [37] Intranasal Low-Dose Naltrexone Against Opioid Side Effects: A Preclinical Study
    Micheli, Laura
    Mannelli, Lorenzo Di Cesare
    Lucarini, Elena
    Parisio, Carmen
    Toti, Alessandra
    Fiorentino, Bruno
    Rigamonti, Maria Adele
    Calosi, Laura
    Ghelardini, Carla
    FRONTIERS IN PHARMACOLOGY, 2020, 11
  • [38] High-dose versus low-dose opioid anesthesia in adult cardiac surgery: A meta-analysis
    Rong, Lisa Q.
    Kamel, Mohamed K.
    Rahouma, Mohamed
    Naik, Ajita
    Mehta, Kritika
    Abouarab, Ahmed A.
    Di Franco, Antonino
    Demetres, Michelle
    Mustapich, Taylor L.
    Fitzgerald, Meghann M.
    Pryor, Kane O.
    Gaudino, Mario
    JOURNAL OF CLINICAL ANESTHESIA, 2019, 57 : 57 - 62
  • [39] In Vivo, In Vitro and In Silico Studies of the Hybrid Compound AA3266, an Opioid Agonist/NK1R Antagonist with Selective Cytotoxicity
    Matalinska, Joanna
    Lipinski, Piotr F. J.
    Kosson, Piotr
    Kosinska, Katarzyna
    Misicka, Aleksandra
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (20) : 1 - 30
  • [40] BU08073 a buprenorphine analogue with partial agonist activity at μ-receptors in vitro but long-lasting opioid antagonist activity in vivo in mice
    Khroyan, T. V.
    Wu, J.
    Polgar, W. E.
    Cami-Kobeci, G.
    Fotaki, N.
    Husbands, S. M.
    Toll, L.
    BRITISH JOURNAL OF PHARMACOLOGY, 2015, 172 (02) : 668 - 680
12345